| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514183000 |
Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI
| 37055 |
| 514100100 |
Peptide (e.g., protein, etc.) containing DOAI
| 8476 |
| 514023000 |
Carbohydrate (i.e., saccharide radical containing) DOAI
| 8375 |
| 514002000 |
Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI
| 3800 |
| 514553000 |
Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI
| 2288 |
| 514169000 |
Cyclopentanohydrophenanthrene ring system DOAI
| 2269 |
| 514075000 |
Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI
| 1769 |
| 514579000 |
Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI
| 1763 |
| 514506000 |
Ester DOAI
| 1439 |
| 514159000 |
Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI
| 469 |
| 514063000 |
Silicon containing DOAI
| 441 |
| 514724000 |
C-O-group (e.g., alcohol, alcoholate, etc.) DOAI
| 379 |
| 514064000 |
Boron containing DOAI
| 331 |
| 514675000 |
Ketone DOAI
| 330 |
| 514167000 |
9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI
| 263 |
| 514152000 |
3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI
| 211 |
| 514476000 |
N-C(=X)X containing (X is chalcogen) DOAI
| 181 |
| 514492000 |
Heavy metal containing DOAI
| 174 |
| 514155000 |
Para-N-benzene - sulfoxy-N containing DOAI, and said benzene ring is not part of a polycyclo ring system
| 147 |
| 514715000 |
Ether DOAI
| 138 |
| 514150000 |
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide DOAI
| 132 |
| 514693000 |
Aldehyde DOAI
| 73 |
| 514762000 |
Hydrocarbon DOAI
| 42 |
| 514706000 |
Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.)
| 38 |
| 514743000 |
Halogenated hydrocarbon DOAI
| 18 |
| 514714000 |
Peroxide DOAI
| 15 |
| 514740000 |
Nitrogen containing compound DOAI
| 13 |
| 514022000 |
Lignin or derivative DOAI
| 12 |
| 514065000 |
Pyrethrum plant derived material or plant derived rotenone compound containing DOAI
| 11 |
| 514149000 |
Azoxy DOAI | 5 |
| 20090186859 | DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS - Disclosed are compounds that release nitric oxide, e.g., a compound of Formula (I) wherein R | 07-23-2009 |
| 20090203653 | Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors - The invention describes novel compositions comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor, and, optionally, at least one therapeutic agent. The invention also provides novel kits comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor compound, and, optionally, at least one therapeutic agent. The invention also provides methods for (a) treating cardiovascular diseases; (b) treating renovascular diseases; (c) treating diabetes; (d) treating diseases resulting from oxidative stress; (e) treating endothelial dysfunctions; (f) treating diseases caused by endothelial dysfunctions; (g) treating gastrointestinal disorders; (h) treating inflammatory disorders; and (j) treating respiratory disorders. The apocynin compound may preferably be apocynin. The nitric oxide donor compound may preferably be isosorbide dinitrate and/or isosorbide mononitrate. | 08-13-2009 |
| 20090281067 | Nitroxyl progenitor compounds and methods of use - Described herein are nitroxyl progenitor compounds, and compositions including, and methods or generating, the compounds thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions. | 11-12-2009 |
| 20090298795 | Thiol-Sensitive Positive Inotropes - The present invention relates to methods for treating diastolic dysfunction or a disease, disorder or condition associated with diastolic dysfunction, methods for treating heart failure, methods for modulating SR Ca2+ release and/or uptake, methods for enhancing myocyte relaxation, preload or E2P hydrolysis, and methods for treating ventricular hypertrophy. | 12-03-2009 |
| 20100298277 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 11-25-2010 |
